These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15588725)

  • 1. Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor.
    Steffens M; Zentner J; Honegger J; Feuerstein TJ
    Biochem Pharmacol; 2005 Jan; 69(1):169-78. PubMed ID: 15588725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids.
    Steffens M; Schulze-Bonhage A; Surges R; Feuerstein TJ
    Neurosci Lett; 2005 Sep; 385(1):13-7. PubMed ID: 15923084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.
    McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA
    Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two cloned human CB1 cannabinoid receptor isoforms.
    Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G
    J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.
    Steffens M; Engler C; Zentner J; Feuerstein TJ
    Br J Pharmacol; 2004 Apr; 141(7):1193-203. PubMed ID: 14993102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the CB1 receptor in the regulation of sleep.
    Murillo-Rodríguez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1420-7. PubMed ID: 18514375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
    Sterin-Borda L; Del Zar CF; Borda E
    Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
    Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and biological effects of CB1 cannabinoid receptor in rat parotid gland.
    Busch L; Sterin-Borda L; Borda E
    Biochem Pharmacol; 2004 Nov; 68(9):1767-74. PubMed ID: 15450942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
    Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
    Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation.
    Choong KC; Su X; Urban MO
    Neurosci Lett; 2007 Mar; 414(2):105-9. PubMed ID: 17194542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids and Their Pharmacological Actions.
    Pertwee RG
    Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of the endocannabinoid system in the effect of TNF-alpha on hypothalamic release of gonadotropin-releasing hormone.
    Fernandez-Solari J; Prestifilippo JP; Bornstein SR; McCann SM; Rettori V
    Ann N Y Acad Sci; 2006 Nov; 1088():238-50. PubMed ID: 17192570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.
    Leggett JD; Aspley S; Beckett SR; D'Antona AM; Kendall DA; Kendall DA
    Br J Pharmacol; 2004 Jan; 141(2):253-62. PubMed ID: 14707029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.
    McLaughlin PJ; Qian L; Wood JT; Wisniecki A; Winston KM; Swezey LA; Ishiwari K; Betz AJ; Pandarinathan L; Xu W; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2006 Mar; 83(3):396-402. PubMed ID: 16616951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells.
    Xiao JC; Jewell JP; Lin LS; Hagmann WK; Fong TM; Shen CP
    Brain Res; 2008 Oct; 1238():36-43. PubMed ID: 18761332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
    Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons.
    Hill EL; Gallopin T; Férézou I; Cauli B; Rossier J; Schweitzer P; Lambolez B
    J Neurophysiol; 2007 Apr; 97(4):2580-9. PubMed ID: 17267760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.
    Duncan M; Millns P; Smart D; Wright JE; Kendall DA; Ralevic V
    Br J Pharmacol; 2004 Jun; 142(3):509-18. PubMed ID: 15148262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.